See the DrugPatentWatch profile for cyklokapron
Have cyklokapron (tranexamic acid) or Lysteda (tranexamic acid) funded any clinical trials?
Based on the information provided here, there is no documented evidence that would let me confirm whether cyklokapron or Lysteda specifically “funded” any particular trials. To answer this accurately, the exact trials (or at least the indication/disease area) and the trial registry identifiers would need to be checked (for example, ClinicalTrials.gov entries that list “Sponsor,” “Sponsor/Collaborator,” or “Funding source”).
Where to check whether a specific sponsor/funder is listed
If you share the trial link(s) or the condition (e.g., heavy menstrual bleeding, dental surgery, trauma/hemorrhage), you can verify funding/sponsorship by looking for:
- Sponsor or Sponsor/Collaborator names on the trial record
- “Responsible Party” and any “Funding”/“Support” fields
- Publications linked to the trial, where author disclosures often identify the study sponsor and financial support
If you tell me the indication, I can narrow it down
If you reply with either:
- the disease/indication (like heavy menstrual bleeding, dental procedures, postpartum hemorrhage), or
- the trial number(s)/registry link(s),
I can help you determine whether the sponsor was the manufacturer of cyklokapron or Lysteda and whether the study was described as supported/financed by them.
What counts as “funded” in trial records?
In trial registries and papers, “funded” can show up as:
- the drug company as sponsor,
- the company as sponsor/collaborator,
- or company-funded research even if it’s registered under a hospital/university.
Without the specific trial(s), it’s not possible to map “funded” to those fields reliably.
---
Sources
No sources were provided with your question, so I cannot cite anything.